IS2257B - Samsetning með aselínsýru - Google Patents
Samsetning með aselínsýruInfo
- Publication number
- IS2257B IS2257B IS5484A IS5484A IS2257B IS 2257 B IS2257 B IS 2257B IS 5484 A IS5484 A IS 5484A IS 5484 A IS5484 A IS 5484A IS 2257 B IS2257 B IS 2257B
- Authority
- IS
- Iceland
- Prior art keywords
- composition
- azelic acid
- acid
- presbyderma
- triacylglyceride
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19753044 | 1997-11-19 | ||
US7485098P | 1998-02-12 | 1998-02-12 | |
DE19808086 | 1998-02-20 | ||
PCT/EP1998/007370 WO1999025332A1 (de) | 1997-11-19 | 1998-11-18 | Zusammensetzung mit azelainsäure |
Publications (2)
Publication Number | Publication Date |
---|---|
IS5484A IS5484A (is) | 2000-05-09 |
IS2257B true IS2257B (is) | 2007-06-15 |
Family
ID=27217979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5484A IS2257B (is) | 1997-11-19 | 2000-05-09 | Samsetning með aselínsýru |
Country Status (21)
Country | Link |
---|---|
US (1) | US6534070B1 (is) |
EP (1) | EP1032379B1 (is) |
JP (1) | JP3867123B2 (is) |
KR (1) | KR100534511B1 (is) |
AT (1) | ATE210438T1 (is) |
AU (1) | AU743437B2 (is) |
BR (1) | BR9814214B1 (is) |
CA (1) | CA2311128C (is) |
CZ (1) | CZ299116B6 (is) |
DE (2) | DE19881737D2 (is) |
DK (1) | DK1032379T3 (is) |
ES (1) | ES2169566T3 (is) |
HU (1) | HU226592B1 (is) |
IL (1) | IL136101A (is) |
IS (1) | IS2257B (is) |
NO (1) | NO327712B1 (is) |
PL (1) | PL202454B1 (is) |
PT (1) | PT1032379E (is) |
SK (1) | SK284338B6 (is) |
TR (1) | TR200001393T2 (is) |
WO (1) | WO1999025332A1 (is) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026982A1 (en) * | 2003-06-10 | 2005-02-03 | Soenke Johannsen | Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient |
DE502004004660D1 (de) * | 2003-06-10 | 2007-09-27 | Intendis Gmbh | Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff |
ATE347367T1 (de) * | 2003-10-13 | 2006-12-15 | Zoser B Salama | Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze |
DE10356288B4 (de) | 2003-11-28 | 2014-04-03 | Siemens Aktiengesellschaft | Röntgendetektorlade |
CA2600054A1 (en) * | 2005-03-09 | 2006-09-21 | Combe Incorporated | Stable mixed emulsions |
CA2600288A1 (en) * | 2005-09-19 | 2007-04-12 | Combe Incorporated | Stable emulsion systems with high salt tolerance |
KR100861978B1 (ko) * | 2007-03-22 | 2008-10-07 | 한국콜마 주식회사 | 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법 |
US8729108B2 (en) * | 2008-06-17 | 2014-05-20 | Christopher J Dannaker | Waterborne topical compositions for the delivery of active ingredients such as azelaic acid |
EP2201930A1 (en) | 2008-12-23 | 2010-06-30 | Intendis GmbH | Hydrogel composition for the treatment of dermatological disorders |
US20100247693A1 (en) * | 2009-03-24 | 2010-09-30 | Marini Jan L | Cosmetic formulation to treat rosacea telangiectasia |
PL217786B1 (pl) * | 2009-05-28 | 2014-08-29 | P P F Hasco Lek Spółka Akcyjna | Żel z kwasem azelainowym i sposób wytwarzania żelu z kwasem azelainowym |
JP2013502436A (ja) | 2009-08-21 | 2013-01-24 | ターゲッティド デリバリー テクノロジーズ リミテッド | 小胞状の製剤 |
DE102010021671A1 (de) | 2010-05-27 | 2011-12-01 | Intendis Gmbh | Azelainsäurehaltige Formulierung mit Pigmentzusatz |
GB201205642D0 (en) * | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
GB201208409D0 (en) * | 2012-05-14 | 2012-06-27 | Sequessome Technology Holdings Ltd | Vesicular formulations, kits and uses |
WO2017001625A1 (en) | 2015-06-30 | 2017-01-05 | Sequessome Technology Holdings Limited | Multiphasic compositions |
US11198831B2 (en) | 2019-01-31 | 2021-12-14 | Kvi Llc | Lubricant for a device |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3811081A1 (de) | 1988-03-30 | 1989-10-12 | Schering Ag | Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut |
ATE117665T1 (de) * | 1990-11-14 | 1995-02-15 | Oreal | Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. |
GB9316323D0 (en) * | 1993-08-06 | 1993-09-22 | Procter & Gamble | Cosmetic compositions |
US5744155A (en) | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
AU5543294A (en) | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
ES2094688B1 (es) | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
US5547989A (en) | 1994-08-19 | 1996-08-20 | Schering-Plough Healthcare Products, Inc. | Compositions for treating corns and calluses |
US5618522A (en) * | 1995-01-20 | 1997-04-08 | The Procter & Gamble Company | Emulsion compositions |
UY24246A1 (es) | 1995-06-06 | 1996-06-14 | Neutrogena Corp | Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado |
-
1998
- 1998-11-18 AU AU17551/99A patent/AU743437B2/en not_active Expired
- 1998-11-18 KR KR10-2000-7005430A patent/KR100534511B1/ko not_active IP Right Cessation
- 1998-11-18 TR TR2000/01393T patent/TR200001393T2/xx unknown
- 1998-11-18 DK DK98962351T patent/DK1032379T3/da active
- 1998-11-18 JP JP2000520766A patent/JP3867123B2/ja not_active Expired - Lifetime
- 1998-11-18 US US09/554,738 patent/US6534070B1/en not_active Expired - Lifetime
- 1998-11-18 CZ CZ20001844A patent/CZ299116B6/cs not_active IP Right Cessation
- 1998-11-18 EP EP98962351A patent/EP1032379B1/de not_active Expired - Lifetime
- 1998-11-18 WO PCT/EP1998/007370 patent/WO1999025332A1/de active IP Right Grant
- 1998-11-18 DE DE19881737T patent/DE19881737D2/de not_active Ceased
- 1998-11-18 AT AT98962351T patent/ATE210438T1/de active
- 1998-11-18 PT PT98962351T patent/PT1032379E/pt unknown
- 1998-11-18 PL PL340631A patent/PL202454B1/pl unknown
- 1998-11-18 CA CA002311128A patent/CA2311128C/en not_active Expired - Lifetime
- 1998-11-18 ES ES98962351T patent/ES2169566T3/es not_active Expired - Lifetime
- 1998-11-18 SK SK708-2000A patent/SK284338B6/sk not_active IP Right Cessation
- 1998-11-18 DE DE59802473T patent/DE59802473D1/de not_active Expired - Lifetime
- 1998-11-18 HU HU0004375A patent/HU226592B1/hu unknown
- 1998-11-18 IL IL13610198A patent/IL136101A/xx not_active IP Right Cessation
- 1998-11-18 BR BRPI9814214-3A patent/BR9814214B1/pt not_active IP Right Cessation
-
2000
- 2000-05-09 IS IS5484A patent/IS2257B/is unknown
- 2000-05-12 NO NO20002487A patent/NO327712B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS2257B (is) | Samsetning með aselínsýru | |
DK0839026T3 (da) | Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler | |
DK0759747T3 (da) | Transdermal indretning til administration gennem de-epitheliseret hud | |
ATE312635T1 (de) | Ventilanordnung | |
ID26773A (id) | Sulfur tersubstitusi pada asam sulfonilaminokarboksilat n-arilamida, persiapan, penggunaan dan persiapan pembuatan obat yang menyertainya | |
DE69512685D1 (de) | Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut | |
DK261490D0 (da) | New pharmaceutical compound | |
HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
ES2168457T3 (es) | Composiciones farmaceuticas que comprenden una superoxido dismutasa. | |
ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
DK0841931T3 (da) | Farmaceutisk sammensætning | |
ATE187890T1 (de) | Ligandgerichtete enzyme-prodrug therapie | |
EA200200853A1 (ru) | Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака | |
MY129121A (en) | Composition with azelaic acid | |
WO2001022917A3 (en) | Effervescent compositions comprising nimesulide | |
WO2000061171A3 (en) | Uses of mammalian ox2 protein and related reagents | |
BR0113886A (pt) | Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit | |
WO2000010590A3 (en) | Cancer treatment | |
BR9801839A (pt) | Medicamento analgésico e aplicação de (+) -0-demetiltramadol. | |
GR77250B (is) | ||
EA199800953A1 (ru) | Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения | |
HUP9903685A2 (hu) | Olanzapin alkalmazása túlzott agresszivitás kezelésére szolgáló gyógyszerkészítmények előállítására | |
PT1313500E (pt) | Associacoes de dalfopristina/quinupristina com o cefpirome | |
BR0015424A (pt) | Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco | |
DK0868181T3 (da) | Anvendelse af alfa,alfa-diphenyleddikesyre-4-(N-methyl-piperidyl)-estere som spasmoanalgetikum |